Back to dashboard
CommercialCoverageMedium impact

06.02.06s, Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations (Independence Administrators)

Independence Blue Cross·Oncology, OB-GYN, Family Medicine +1 more·Medical Policy
Effective date
Nov 26, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

Independence Administrators has reissued their genetic testing policy for BRCA1 and BRCA2 mutations, effective November 26, 2025. This appears to be a routine policy reissuance with updated language or criteria for inherited breast cancer genetic testing coverage.

Action Required

Action needed
By November 26, 2025: Billing team should review the complete updated policy at the source URL to identify any changes in coverage criteria, prior authorization requirements, or billing guidelines for BRCA genetic testing. Update encounter forms and billing procedures accordingly once full policy details are available.

Related policy hubs